lenvatol 10mg (lenvatinib)

Lenvatol 10mg, a generic version of lenvatinib, is a kinase inhibitor used to treat various medical conditions. It is recommended for the following:

• As a single agent, Lenvatol 4mg can be used to treat locally recurrent or metastatic, progressive, radioactive iodine-refractory Differentiated Thyroid Cancer (DTC).
• In combination with everolimus, Lenvatol 4mg is indicated for patients with advanced Renal Cell Cancer (RCC) who have previously undergone one anti-angiogenic therapy.
• For patients with unresectable Hepatocellular Carcinoma (HCC), Lenvatol 4mg is used as a first-line therapy.

 lenvatinib DOSAGE

• The recommended dosage of Lenvatol 10mg varies depending on the medical condition being treated:

  • For patients with Differentiated Thyroid Cancer (DTC), the recommended dose is 24 mg orally, once a day.
  • For patients with Renal Cell Cancer (RCC), the recommended dose is 18 mg of Lenvatinib plus 5 mg of everolimus, taken orally once daily.
  • For patients with Hepatocellular Carcinoma (HCC), the recommended dose is 12 mg orally, once a day for individuals weighing over 60 kg, and 8 mg orally, once a day for those weighing less than 60 kg.

  It is crucial to follow the administration instructions for Lenvatol 10mg as prescribed by a healthcare professional. For patients with severe renal or hepatic impairment, the dose should be reduced to 14 mg once a day for DTC and 10 mg once a day for RCC. Depending on the individual patient factors and response to treatment, dose modifications may be required.

lenvatinib 10mg Side Effects：

Lenvatinib, an effective treatment for thyroid and kidney cancer, can result in side effects. The most common side effects experienced by people being treated for thyroid cancer are tiredness, joint and muscle pain, weight loss, mouth sores, vomiting, stomach pain, decreased appetite, nausea, headache, hoarseness, and skin rash, redness, itching or peeling on the hands and feet.

For people being treated for kidney cancer, the most common side effects of lenvatinib include tiredness, decreased appetite, nausea, swelling in the arms and legs, stomach pain, rash, joint and muscle pain, vomiting, mouth sores, cough, difficulty breathing, weight loss, and bleeding.

It's essential to address any concerns about fertility problems that may arise from taking lenvatinib with a healthcare provider.

lenvatinib cost in India:

The cost of lenvatinib 4mg in India is only 4% of the cost in the United States.

Lenvima PI:

To obtain additional prescribing information, please refer to the "FDA Prescribing Information."